Beatriz Mateos

6PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)HaematologyPacific Peoples theory of change models for healthAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 10, 2026
Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapy.

|Jan 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.

Georg Semmler, Sonia Alonso López, Monica Pons

|Jul 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.

Georg Semmler, Sonia Alonso López, Monica Pons

|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.

Mar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban

|May 02, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns

|Jan 10, 2023
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Álvaro Díaz-González, Manuel Hernández-Guerra, Indhira Pérez-Medrano

Pageof 1

Frequent Collaborators

4 joint publications

Xavier Forns

3 joint publications

Mar Riveiro-Barciela

2 joint publications

Manuel Hernández-Guerra

2 joint publications

Ana Arencibía